A
·
B
·
C
·
D
·
E
·
F
·
G
·
H
·
I
·
J
·
K
·
L
·
M
·
N
·
O
·
P
·
Q
·
R
·
S
·
T
·
U
·
V
·
W
·
X
·
Y
·
Z
·
OTHER
·

Directory Results for CEOR-47486-cost-effectiveness-of-stribild-compared-with--as-firs First-line HIV cost-effectiveness to CEOR-53142-cost-effectiveness-analysis-of-mammostrat-compared-to-oncoty Comparative cost-effectiveness analysis of Mammostrat versus Oncotype DX

CEOR-47486-cost-effectiveness-of-stribild-compared-with--as-firs First-line HIV cost-effectiveness
CEOR-5101-clinical-and-economic-considerations-of-anti-obesity-treatme. Anti-obesity treatments and review of orlistat
CEOR-52967-comparison-of-cost-of-non-operative-care-to-minimally-invasi US costs of nonoperative care versus MIS in SI joint disruption
CEOR-53142-cost-effectiveness-analysis-of-mammostrat-compared-to-oncoty Comparative cost-effectiveness analysis of Mammostrat versus Oncotype DX